Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Colorcon
Baxter
Argus Health
Novartis
Merck
QuintilesIMS
Boehringer Ingelheim
Johnson and Johnson
Chinese Patent Office

Generated: October 21, 2017

DrugPatentWatch Database Preview

CHLORPROMAZINE HYDROCHLORIDE INTENSOL Drug Profile

« Back to Dashboard

Which patents cover Chlorpromazine Hydrochloride Intensol, and when can generic versions of Chlorpromazine Hydrochloride Intensol launch?

Chlorpromazine Hydrochloride Intensol is a drug marketed by Cycle Pharms Ltd and is included in two NDAs.

The generic ingredient in CHLORPROMAZINE HYDROCHLORIDE INTENSOL is chlorpromazine hydrochloride. There are twenty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.

Summary for Tradename: CHLORPROMAZINE HYDROCHLORIDE INTENSOL

US Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list56
Clinical Trials: see list2,304
Patent Applications: see list1,797
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CHLORPROMAZINE HYDROCHLORIDE INTENSOL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cycle Pharms Ltd
CHLORPROMAZINE HYDROCHLORIDE INTENSOL
chlorpromazine hydrochloride
CONCENTRATE;ORAL088157-001Apr 27, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Cycle Pharms Ltd
CHLORPROMAZINE HYDROCHLORIDE INTENSOL
chlorpromazine hydrochloride
CONCENTRATE;ORAL088158-001Apr 27, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Teva
Chinese Patent Office
McKinsey
Accenture
Moodys
Daiichi Sankyo
Fuji
Covington
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot